Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 5
Submit an article Journal homepage
567
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Oxcarbazepine in bipolar disorder: a critical review of the literature

Marianna Mazza Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Marco Di Nicola Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Giovanni Martinotti Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Colombo Taranto Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Gino Pozzi Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Gianluigi Conte Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Luigi Janiri Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
,
Pietro Bria Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy
&
Salvatore Mazza Department of Neurosciences, Epilepsy Center, Catholic University of Sacred Heart, Rome, Italy. [email protected],[email protected]
 show all
Pages 649-656 | Published online: 22 Mar 2007

Bibliography

  • KRUGER S, YOUNG LT, BRAUNIG P: Pharmacotherapy of bipolar mixed states. Bip. Disord. (2005) 7:205-215.
  • HELLEWELL JSE: Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J. Affect. Disord. (2002) 72:S23-S34.
  • FRENCH JA, KANNER AM, BAUTISTA J et al.: Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy; a report of the Therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2004) 62:1261-1273.
  • AMERICAN PSYCHIATRIC ASSOCIATION (APA): Practice guidelines for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry (2002) 159(S4):1-50.
  • SUPPES T, DENNEHY EB, SWANN AC: Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. J. Clin. Psy. (2000) 63:288-299.
  • KETTER TA, WANG PW, BECKER OV et al.: The diverse roles of anticonvulsants in bipolar disorders. Ann. Clin. Psychiatry (2003) 15(2):95-108.
  • MAY TW, KORN-MERKER E, RAMBECK B: Clinical pharmacokinetics of oxcarbazepine. Clin. Pharmacokinet. (2003) 42:1023-1042.
  • SCHMIDT D, ELGER CE: What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav. (2004) 5:627-635.
  • PRATOOMSRI W, YATHAM LN, BOND DJ et al.: Oxcarbazepine in the treatment of bipolar disorder: a review. Can. J. Psychiatry (2006) 51(8). 540-545.
  • GOODNICK PJ: Anticonvulsants in the treatment of bipolar mania. Expert. Opin. Pharmacoter. (2006) 7(4):401-410.
  • LOFGEN E, TAPANAINEN JS, KOIVUNEN R et al.: Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia (2006) 47(9):1441-1446.
  • VAN AMELSVOORT T, BAKSHI R, DEVAUX CB et al.: Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia (1994) 35(1):181-188.
  • DONG X, LEPPIK IE, WHITE J: Hyponatremia from oxcarbazepine and carbamazepine. Neurology (2005) 65:1976-1978.
  • MAVRAGANI CP, PANAYIOTIS G, VLACHOYIANNOPOULOS G: Is polydipsia sometimes the cause of oxcarbazepine-induced hyponatremia? Eur. J. Int. Med. (2005) 16:296-297.
  • SACHDEO RC, WASSERSTEIN A, MESENBRINK PJ: Effects of oxcarbazepine on sodium concentration and water handling. Neurology (2002) 51:613-620.
  • MINTZER S, BOPPANA P, TOGURI J: Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia (2006) 47(3):510-515.
  • JEFFERSON J: Oxcarbazepine in bipolar disorder. Prim. Care Compan. J. Clin. Psy. (2001) 3(4):181.
  • EMRICH HM, ALTMANN H, DOSE M: Therapeutic effects of GABA-ergic drugs in affective disorders: a preliminary report. Pharmacol. Biochem. Behav. (1983) 19:369-373.
  • EMRICH HM: Studies with oxcarbazepine (Trileptal) in acute mania. Int. Clin. Psychopharmacol. (1990) 5(S1):83-88.
  • HUMMEL B, WALDEN J, STAMPFER R: Acute antimanic efficay anf safety of oxcarbazepine in an open trial with an on-off-on design. Bip. Disord. (2002) 4:412-417.
  • GHAEMI SN, BERV DA, KLUGMAN J: Oxcarbazepine treatment of bipolar disorder. J. Clin. Psy. (2003) 64:943-945.
  • RAJA M, AZZONI A: Oxcarbazepine versus valproate in the treatment of mood and schizoaffective disorders. Int. J. Neuropsychopharmacol. (2003) 6:409-414.
  • CENTORRINO F, ALBERT MJ, BERRY JM et al.: Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bip. Disord. (2003) 5:370-374.
  • BENEDETTI A, LATTANZI L, PINI S: Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. J. Affect. Disord. (2004) 79:273-277.
  • PRATOOMSRI W, YATHAM LN, SOHN CH: Oxcarbazepine add-on in the treatment of refractory bipolar disorder. Bip. Disord. (2005) 7(5):37-42.
  • MATTES JA: Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. (2005) 25(6):575-579.
  • CONWAY CR, CHIBNALL JT, NELSON LA et al.: An open-label trial of adjunctive oxcarbazepine for bipolar disorder. J. Clin. Psychopharmacol. (2006) 26(1):95-97.
  • WAGNER KD, KOWATCH RA, EMSLIE GJ et al.: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am. J. Psychiatry (2006) 163:1179-1186.
  • MORENO RA, HUPFELD MORENO D, DE MACEDO SOARES MB et al.: Anticonvulsants and antipsychostics in the treatment of bipolar disorder. Rev. Bras. Psi. (2004) 26(S III):37-43.
  • MAZZA M, BRIA P, MAZZA S: Efficacy and safety of oxcarbazepine (OXC) in bipolar disorder. Can. J. Psychiatry In press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.